whitepaper

ebook: Accelerate vaccine development

Posted: 13 May 2021 | | No comments yet

Our comprehensive portfolio suite is designed to optimize your productivity to get safe and efficacious vaccines and therapeutics to market faster.

Immunology is now, more than anytime in recent history, one of the top fields of research. With antibody-drug conjugate and bispecific antibody products recently reaching the market, the use of mAbs will remain a key part of therapeutic development.

Learn more about:

  • Automated screening & selection of high-expressing cell lines
  • Novel antibody internalization and binding assays
  • Easy expression assays
  • Objective verification of monoclonalit












    To read this ebook in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Molecular Devices

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Send this to a friend